Given the high level expression of FRA in adenocarcinoma, in contrast to its very limited expression in squamous cell carcinoma, the present data supports further studies on FRA expression and its potential inclusion in IHC panels used for sub-classification of NSCLC. Here, FOLR1 is linked to adenocarcinoma.